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Abstract
Rationale—The co-abuse of ethanol (EtOH) and nicotine (NIC) increases the likelihood that an 
individual will relapse to drug-use while attempting to maintain abstinence. There is limited 
research examining the consequences of long-term EtOH and NIC co-abuse.
Objectives—The current experiments determined the enduring effects of chronic EtOH, NIC, or 
EtOH + NIC intake on the reinforcing properties of NIC and glutamate (GLU) activity within the 
mesocorticolimbic (MCL) system.
Methods—Alcohol-preferring (P) rats self-administered EtOH, Sacc + NIC or EtOH + NIC 
combined for 10 weeks. The reinforcing properties of 0.1–3.0 uM NIC within the nucleus 
accumbens shell (AcbSh) were assessed following a 2–3 week drug-free period using intracranial 
self-administration (ICSA) procedures. The effects of EtOH, Sacc, Sacc + NIC or EtOH + NIC 
intake on extracellular levels and clearance of glutamate (GLU) in the medial prefrontal cortex 
(mPFC) were also determined.
Results—Binge intake of EtOH (96–100 mg%) and NIC (21–27 mg/ml) were attained. All 
groups of P rats self-infused 3.0 uM NIC directly into the AcbSh; whereas only animals in the 
EtOH + NIC co-abuse group self-infused the 0.3 and 1.0 uM NIC concentrations. Additionally, 
self-administration of EtOH + NIC, but not EtOH, Sacc or Sacc + NIC, resulted in enduring 
increases in basal extracellular GLU levels in the mPFC.
Conclusions—Overall, the co-abuse of EtOH + NIC produced enduring neuronal alterations 
within the MCL which enhanced the rewarding properties of NIC in the AcbSh and elevated 
extracellular GLU levels within the mPFC.
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INTRODUCTION
Alcohol use and smoking are two of the leading preventable causes of disease and death in 
the United States (Mokdad et al. 2004). For many individuals, the co-use/abuse of alcohol 
(EtOH) and nicotine (NIC) go hand in hand (John et al. 2003a,b; DiFranza and Guerrera 
1990). Within the clinical population, EtOH and/or NIC addiction proceeds in a chronic 
recurring fashion with alternating periods of abstinence and relapse (NIDA, 2015). 
Individuals that co-abuse EtOH and NIC exhibit a significantly poorer clinical outcome (i.e., 
higher relapse rates), when attempting to maintain abstinence, than individuals who use only 
one of the drugs (Lajtha and Sershen 2010). Thus, there is a need to better understand the 
neurobiological mechanisms underlying the interactions of EtOH and NIC that contribute to 
their high co-morbidity and increased risk of relapse when an individual co-abuses these 
drugs.
The medial prefrontal cortex (mPFC) is involved in higher-order processing/cognitive 
functioning in mammals and possesses reciprocal projections with several sub-cortical brain 
structures within the mesolimbic reward pathway (Hoover & Vertes, 2007; Steketee, 2003). 
There is evidence that the GLU system within the mPFC is involved in the manifestation of 
drug-seeking (Ma et al., 2014; Miller & Marshall, 2004; Peters et al., 2008: Stefanik et al., 
2013) and an alteration in the homeostatic balance of glutamate (GLU) in this area may 
precipitate drug relapse (Kalivas, 2009). The mPFC receives major GLU projections from 
the basolateral nucleus of the amygdala (BLA), dorsal thalamus, and the hippocampus 
(Hoover & Vertes, 2007) and sends GLU afferents to downstream reward associated 
structures including the nucleus accumbens (Acb) (Steketee, 2003). Thus, alteration in GLU 
functioning within the mPFC would affect downstream structures also intricately linked to 
drug reward and relapse. Given that recent research has indicated chronic EtOH (Holmes et 
al., 2012) or chronic NIC (Wang et al., 2007, 2008) have both been shown to alter GLU 
function within the mPFC, it is likely that this structure possesses an important role in the 
co-abuse of EtOH and NIC.
Several sub-cortical structures within the mesocorticolimbic (MCL) system have been 
established as critical components of drug reward/reinforcement. Animals will directly self-
administer EtOH and NIC into the posterior ventral tegmental area (pVTA) at 
pharmacologically relevant concentrations (Hauser et al. 2014; Rodd et al. 2004). Moreover, 
EtOH is self-infused into the nucleus accumbens shell (AcbSh) (Engleman et al., 2009). A 
recent study provided evidence that EtOH and NIC act synergistically to produce 
reinforcement within the pVTA. Male and female alcohol-preferring (P) rats exhibited 
reliable operant responding for a combination of sub-threshold concentrations of EtOH and 
NIC (50 mg% and 1 μM respectively) but failed to reliably infuse either compound alone 
(Truitt et al., 2015). Exposure of midbrain slices to low concentrations of EtOH and NIC 
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resulted in stimulation of VTA dopamine (DA) neurons that was not observed following 
equivalent exposure to EtOH or NIC alone (Clark and Little 2004). To date, there has been 
limited research examining the interactions of chronic EtOH and NIC. Recently, chronic 
EtOH and NIC consumption was readily obtained through the use of an operant oral self-
administration model (Hauser et al. 2012). In this paradigm, the drug intake of alcohol-
preferring (P) rats produced binge-like blood-EtOH levels and blood-NIC levels comparable 
to that observed in chain-smokers (Hauser et al. 2012), providing a useful model in which to 
examine the neurobiological ramifications of EtOH and NIC co-abuse.
The current experiments were conducted to examine the consequences of the chronic co-
abuse of EtOH and NIC followed by an imposed abstinence on the rewarding properties of 
NIC within the AcbSh as well as basal extracellular levels and clearance of GLU within the 
mPFC. The hypothesis to be tested was that EtOH and NIC co-abuse produces enduring 
behavioral and neurobiological alterations within the MCL system that are not observed 
following the abuse of EtOH or NIC individually.
MATERIALS AND METHODS
Animals
Female P rats, from the 68th – 71st generations weighing 250–320 g at the time of surgery 
were used. Rats were double-housed upon arrival and maintained on a 12-hr reverse light-
dark cycle (lights off at 0900 hr). Food and water were freely available except in the test 
chamber. Animals used in this study were maintained in facilities fully accredited by the 
Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC). 
All research protocols were approved by the institutional animal care and use committee and 
are in accordance with the guidelines of the Institutional Care and Use Committee of the 
National Institute on Drug Abuse, NIH, and the Guide for the Care and Use of Laboratory 
Animals (Research Institute for Laboratory Animal Research, 2011).
EtOH, Sacc + NIC, and EtOH and NIC Operant Self-Administration
Ethyl alcohol (190 proof; McCormick Distilling Co., Weston, MO) was diluted using 
distilled water to concentrations of 10, 20, and 30% vol/vol. NIC HCl was purchased from 
Sigma (St. Louis, USA). NIC concentrations of 0.07 and 0.14 (salt) mg/mL were dissolved 
in 0.0125% saccharin (Sacc) or 10%, 20% and 30% EtOH for operant oral self-
administration sessions.
Self-administration of EtOH and EtOH + NIC occurred in 3-lever operant conditioning 
chambers (Coulbourn Instruments) contained within ventilated, sound-attenuated enclosures. 
Water was available constantly throughout testing through a drinking sprout located on the 
wall opposite the levers. Naïve P rats were placed into the operant conditioning chamber, 
without prior training. Operant conditioning sessions were 60-min in duration and occurred 
daily for 10 weeks (Rodd et al. 2006). All levers were maintained on an FR1 schedule of 
reinforcement for 4 weeks then increased to an FR-3 schedule for 3 weeks, and then to an 
FR-5 schedule for 3 weeks. Animals in the EtOH alone group had concurrent access to 10%, 
20%, and 30% EtOH. The EtOH and NIC (EtOH + NIC) co-administration group was given 
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concurrent access to 10%, 20%, and 30% EtOH with 0.14 mg/mL NIC added to each. The 
water control group had water available from all 3 levers. All Sacc + NIC groups had 
concurrent access to 0.0125% Saccharin (Sacc) with 0.07 mg/mL or 0.14 mg/mL NIC in a 
two-lever operant conditioning chamber to obtain similar blood-nicotine levels as rats in the 
EtOH + NIC group. Past data indicated these procedures would result in equivalent blood 
and intake levels for NIC across all groups (Hauser et al. 2012).
It is important to note that a Sacc alone group was only employed during the GLU no-net-
flux experiment. Prior research indicated that Sacc does not induce neurochemical 
alterations in the Acb during operant conditioning (Melendez et al. 2002, 2004). Therefore, 
use of a Sacc alone control group was limited to the GLU no-net-flux experiment to 
minimize overall animal numbers and cost.
Effects of Chronic EtOH, Sacc + NIC, and EtOH + NIC Intake on the self-infusion of NIC into 
the AcbSh
All animals received 10 weeks of access to their assigned fluids, and were then deprived for 
1 week prior to surgery. Further details of the surgical procedure, test chambers and general 
test conditions are provided in other reports (e.g., Hauser et al. 2014; Rodd et al. 2005). 
Briefly, animals were implanted with a guide cannula aimed at the AcbSh at least 7 days 
after the last operant oral self-administration session. All rats experienced a least 2 weeks of 
abstinence prior to testing. The ICSA operant conditioning chamber was equipped with two 
levers. Depression of the ‘active lever’ (FR1 schedule of reinforcement) caused the delivery 
of a 100-nl bolus of infusate over 5 sec followed by a 5-sec time-out period. During both the 
5-sec infusion period and 5-sec time-out period, responses on the active lever did not 
produce further infusions. Responses on the ‘inactive lever’ were recorded, but did not result 
in infusions. The assignment of active and inactive lever with respect to the left or right 
position was counterbalanced among subjects. The active and inactive levers remained the 
same for each rat throughout the experiment. The number of infusions and responses on the 
active and inactive lever were recorded. The duration of each test session was 4 hr and 
sessions occurred every other day.
Rats with previous drinking history of water, EtOH, Sacc + NIC, or EtOH + NIC (n = 135) 
were randomly assigned to one of 5 NIC concentration groups (n = 6–8/drinking 
history/NIC concentration). A vehicle group received infusions of aCSF for all seven 
sessions. The other groups received infusions of 0.1, 0.3, 1.0, or 3.0 μM NIC for the first 
four sessions (acquisition). During the fifth and sixth sessions, all animals received infusions 
of aCSF and the original infusate was returned on the seventh session (reinstatement).
Effects of Chronic EtOH, Sacc, Sacc + NIC, and EtOH + NIC Consumption on Basal 
Extracellular levels and Clearance of GLU in the mPFC
All animals underwent operant conditioning identical to that previously reported by Hauser 
et al. (2012)
. Approximately nine-days after the completion of operant testing, all animals 
were anesthetized using 2% isoflurane and implanted unilaterally with a single guide 
cannula (Plastics One, Inc., Roanoke, VA, USA) aimed approximately 1.0 mm above the 
mPFC (AP +3.0 mm, ML −0.7 mm, DV −2.0 mm; Paxinos and Watson 2005). Immediately 
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following surgery a dummy stylet was inserted into the cannula and remained in place until 
probe insertion. Following surgery, all rats were single housed and provided 7 days to 
recover prior to the start of testing. During the final 3 days of recovery, all rats underwent 
daily handling and habituation to the microdialysis chambers. On the final recovery day, 
loop style microdialysis probes (active length 2.0 mm, Spectra/Por RC, inner diameter 200 
μM, molecular weight cut-off: 13,000, Spectrum laboratories, Inc, Rancho Dominguez, CA) 
were inserted into the mPFC following handling/habituation. Approximately 24 hr after 
probe insertion (16 days after the final operant conditioning session), five groups of rats 
(n=6–8/group: water, EtOH, Sacc + NIC, EtOH + NIC, or Sacc) underwent quantitative 
microdialysis for GLU in the mPFC in which samples were collected every 10 min, at a flow 
rate of 2 μl/min, by perfusing artificial cerebral spinal fluid (aCSF) followed by aCSF 
containing 1 of 3 GLU concentrations (1, 5, and 10 μM) in randomized order across rats. 
Each GLU concentration was perfused for a total of 5 samples (50 minutes). Following the 
completion of microdialysis, animals were euthanized, brains were extracted, and 
histological analysis was performed to verify placement of the microdialysis probes in the 
mPFC. All samples were analyzed using high-pressure chromatography (HPLC) with 
electrochemical detection. Animals with a probe location outside the mPFC were excluded 
from statistical analyses.
Histology
At the termination of the ICSA and microdialysis experiments, 1% bromophenol blue (0.5 
uL) was injected or perfused through the microdialysis probe. Subsequently, the animals 
were given a fatal dose of carbon dioxide and then decapitated. Brains were removed and 
immediately frozen at −70° C. Frozen brains were subsequently equilibrated at −15° C in a 
cryostat microtome and then sliced into 40 μm sections. Sections were then stained with 
cresyl violet and examined under a light microscope for verification of the injection site 
using the rat brain atlas of Paxinos and Watson (2005).
Statistical Analysis
Data analysis for the ICSA experiment consisted of a drinking history × concentration × 
session mixed ANOVA with a repeated measure of ‘session’ was performed on the number 
of infusions. Additionally, for each individual group, lever discrimination was determined by 
a lever (active or inactive) × session mixed ANOVA with a repeated measure of ‘session’. 
Quantitative microdialysis data were analyzed using multiple linear regression and one-way 
ANOVA’s as previously described (Ding et al. 2013). The slope (extraction fraction; in vivo 
recover of GLU) and the × intercept (basal GLU level) were calculated by comparing the 
GLU concentration perfused through the probe with the GLU concentration that was 
collected for each sample. Group differences were analyzed with multiple linear regression 
modeling and the effects of EtOH and/or NIC were analyzed with one-way ANOVA’s using 
SAS System for Windows version 8.02 (SAS Institute Incorporated, Cary, NC).
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RESULTS
Operant Oral Self-Administration
During the final week of operant testing rats exhibited binge like intake of the test solutions 
at levels that produced blood ethanol concentrations (BECs) in excess of 96 mg% and blood 
NIC levels in excess of 21 mg/mL with no significant differences in lever responding 
between groups (data not shown). The rate of acquisition of EtOH, NIC, and EtOH + NIC 
self-administration was comparable, therefore, the total duration and amount of drug 
exposure was equivalent between groups (Hauser et al. 2012).
Effects of Chronic EtOH, NIC, and EtOH + NIC Consumption on the self-infusion of NIC into 
the AcbSh
The mixed ANOVA conducted on the average number of infusions received during the initial 
4 ICSA test sessions (Fig 1) revealed a significant ‘drinking history’ × ‘nicotine 
concentration’ interaction (F12,115 = 26.61; p < 0.0001). However, there was no significant 
effect of ‘drinking history’ for each NIC concentration on the self-infusion of either aCSF or 
0.1 μM NIC into the AcbSh (F values < 0.323; p values < 0.81). In contrast, there were 
significant effects of ‘drinking history’ for the self-infusion of 0.3, 1.0, and 3.0 μM NIC into 
the AcbSh (F values > 37.62; p values < 0.0001). Post-hoc analysis (Tukey’s b) indicated 
that 0.3, 1.0, and 3.0 μM NIC were self-infused more frequently into the AcbSh by rats with 
a past drinking history of EtOH + NIC than in all other groups. Examining the effect of 
‘NIC concentration’ in each ‘drinking history’ group revealed that the number of self-
infusion varied across the concentration of NIC self-administered (F values > 15.89; p 
values < 0.001). Rats with a past drinking history of water, EtOH, or NIC, self-infused 3.0 
μM NIC directly into the AcbSh at a significantly higher rate than aCSF. Rats that consumed 
EtOH + NIC self-infused significantly more 0.3, 1.0, and 3.0 μM NIC than aCSF controls 
while the 1.0, and 3.0 μM NIC groups received significantly more self-infusions than the 0.3 
μM NIC group.
A repeated measure ANOVA with a within subject factor of ‘session’ and between subject 
factors of ‘drinking history’ and ‘nicotine concentration’ was performed on the number of 
active lever responses. Overall, the analysis revealed a significant ‘drinking history’ × 
‘nicotine concentration’ × ‘session’ interaction (F72, 690 = 3.48; p < 0.0001). There was no 
significant effect of ‘session’ or ‘drinking history’ for the aCSF or 0.1 μM NIC groups (data 
not shown) (F values < 1.27; p values > 0.237). Rats that self-infused 0.3, 1.0, or 3.0 μM 
NIC exhibited significant ‘drinking history’ × ‘session’ interactions (F values > 2.34; p 
values < 0.008). The active lever presses for each individual session by rats self-infusing 0.3 
μM NIC (Fig. 2) revealed a significant effect of ‘drinking history’ during the 2nd–4th test 
sessions (F3,22 values > 9.87; p < 0.0001). Post-hoc comparisons revealed that the EtOH + 
NIC group responded significantly more on the active lever during these sessions compared 
to all other groups.
Evidence for extinction during aCSF substitution was evident by the lack of an effect of 
‘drinking history’ during session 6 (F3,22 = 1.738; p = 0.19). The return of NIC into the 
infusate during session 7 resulted in significant effect of ‘drinking history’ (F3,22 = 33.1; p < 
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0.0001) as the EtOH + NIC group responded more on the active lever compared to all other 
groups. Rats self-infusing 1.0, or 3.0 μM NIC (Figs. 3 and 4), exhibited a significant effect 
of ‘drinking history’ on active lever responses during sessions 1–4 (F values > 16.1; p values 
< 0.0001), and post-hoc comparisons indicated that lever responses were greater in the EtOH 
+ NIC group compared to all other groups. Further examination of the 3-way interaction for 
active lever responding revealed that responding for 3.0 μM NIC (Fig 4) was significantly 
higher in rats with a past drinking history of water, EtOH, or NIC compared to aCSF 
controls. In rats with a past drinking history of EtOH + NIC, active lever responding for 0.3, 
1.0, or 3.0 μM NIC was greater than for aCSF (1.0 and 3.0 μM NIC > 0.3 μM NIC).
Rats self-infusing 3.0 μM NIC displayed lever discrimination between the active and 
inactive lever (p values < 0.003) during sessions 1–4 and 7. Lever discrimination was not 
observed during session 6 in all groups (p > 0.23). Lever discrimination was observed in rats 
with a past drinking history of EtOH + NIC self-infusing 0.3 and 1.0 μM NIC (bottom right 
panels; Figs 2 and 3), sessions 2–4 and 1–4, respectively (p values < 0.004). These rats 
failed to discriminate between active and inactive levers during sessions 5 and 6 (aCSF 
substitution). There was a significant ‘drinking history’ × ‘nicotine concentration’ × 
‘session’ interaction (F72, 690 = 1.93; p < 0.001) for inactive lever responding. Post-hoc 
analysis revealed that for rats self-infusing NIC during sessions 1–4 (as indicated by 
significantly higher level of responding compared to aCSF controls), there was an increase 
in inactive lever responding during the 1st aCSF substitution session (session 6; Figs. 2–4). 
Increase in inactive lever responding during the 1st aCSF substitution session has been 
observed for cocaine and EtOH ICSA in P rats (Rodd et al. 2005; Rodd-Henricks et al. 
2002; Katner et al. 2011). This increase in inactive lever responding is thought to be 
indicative of drug-seeking.
Effects of Chronic EtOH, NIC, and EtOH + NIC Consumption on Basal Extracellular Levels 
and Clearance of GLU in the mPFC
Representative probe placements within the mPFC are illustrated in Figure 5. Animals with 
cannula/probe placements outside of the mPFC were excluded from analyses. Analysis of 
the × intercepts using a univariate ANOVA revealed a significant effect of group on basal 
extracellular GLU levels, F(4,29) = 7.10, p < 0.05. Analyzing the main effect further, a 
Tukey’s b post hoc analysis found that extracellular GLU levels were significantly higher in 
the EtOH +NIC group (8.1 ± 2 μM) than all other groups: Water 2.3 ± 0.5 μM, EtOH 3.5 
± 0.75 μM, SAC 2.7 ± 0.4 μM, SAC + NIC 1.7 ± 0.5 μM (Fig. 6; p < 0.05). With regard to 
GLU clearance, a univariate ANOVA on the extraction fractions obtained via multiple linear 
regression analysis revealed a significant effect of group, F(4,29) = 17.15, p < 0.05. An 
additional Tukey’s b post-hoc analysis observed a significantly higher level of GLU 
clearance in the mPFC of rats that consumed SAC + NIC (70 ± 3%) compared to all other 
groups: Naïve 30 ± 5%, EtOH 20 ± 7%, EtOH +NIC 24 ± 4%, and SAC 35 ± 2% (p<0.05).
DISCUSSION
Overall, the current data indicates that the effects of EtOH and NIC co-abuse cannot be 
summarized as simple modifications to neuroadaptations produced by comparable intake of 
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EtOH or NIC. In contrast to the expected additive or synergistic effects of EtOH and NIC 
co-abuse, the data indicate that co-abuse modifies glutamatergic functioning within the 
mPFC in a unique manner. Further, the present data are the first to indicate that NIC is self-
administered within the AcbSh. Smokers can readily obtain blood NIC concentrations that 
exceed the levels that were used in the current experiment (Benowitz, 1997). P rats will 
orally self-administer solutions of EtOH + NIC (15% and 0.14 mg/mL) at rates that produce 
blood EtOH and NIC concentrations that approach those used in the current experiments 
(>80 mg% and 27 ng/mL, respectively; Hauser et al. 2012). The actual concentration of NIC 
in the brain following microinjection is likely lower than those achieved in the current ICSA 
experiments, and may approach the levels observed following oral EtOH + NIC self-
administration in P rats (167 nM; 0.167 μM). Thus, the ICSA findings suggest that 
biologically relevant levels of NIC are reinforcing within the AcbSh.
The reinforcing properties of NIC in the AcbSh are likely to be mediated, in part, by the 
dopaminergic and glutamatergic systems. Local application of NIC into the AcbSh increases 
extracellular concentrations of DA and GLU (Toth et al. 1992; Marshall et al. 1997). 
Microinjections of DA antagonists into the AcbSh block the rewarding properties of 
systemically administered NIC (Sun et al. 2014). Chronic systemic administration of EtOH 
and NIC can alter GLU levels within the Acb (Lallemand et al. 2011). Nicotinic 
acetylcholine receptors (NAchRs; α4β2, α6β2, and α4α6β2β3) in the AcbSh are located 
presynaptically on DA terminals that emerge from distinct DA fiber pathways possessing 
distinct firing characteristics (Meyer et al. 2008). Presynaptic α7 NAchRs on glutamatergic 
input into the AcbSh positively mediate the release of GLU and indirectly mediate the 
release of DA (c.f., Livingstone and Wonnacott 2009). Activation of α7 receptors by NIC 
stimulated the release of GLU which acts on ionotropic presynaptic GLU receptors that 
stimulate DA release (Innocent et al. 2008). In addition, alterations in the stoichiometry of 
the α4β2 NAchR from a (α4)2(β2)3 to an (α4)3(β2)2 greatly enhances the sensitivity of the 
receptor to the actions of NIC (Nelson et al. 2003). However, alterations in NAchRs 
produced by NIC exposure are typically short lived, and would likely not be present during 
subsequent ICSA testing (at least 14 days after last operant conditioning session; Nelson et 
al. 2003).
Similar to the ICSA data set, the analysis of the effects of chronic EtOH, NIC, or EtOH + 
NIC consumption on the glutamatergic system in the mPFC indicated enduring unique 
alterations produced by EtOH + NIC co-abuse (Fig. 6). Chronic EtOH + NIC co-abuse 
resulted in a persistent (16 days following last operant self-administration session) alteration 
in basal GLU levels within the mPFC (> 3 fold-increase compared to water controls). 
Consumption of equivalent levels of EtOH or NIC did not alter basal GLU levels (Fig. 6; top 
panel). Such an increase of GLU levels within the mPFC has been postulated as an indicator 
of a predisposition for heightened drug seeking (Kalivas et al. 2009). Manipulations that 
reduce GLU activity in discrete regions of the mPFC can inhibit drug-seeking and NIC 
reward (Paterson et al. 2003; Kalivas and O’Brien 2008). P rats that co-abused EtOH and 
NIC expressed a greater and more prolonged context-induced drug-seeking than P cohorts 
that self-administered equivalent levels of EtOH or NIC (Hauser et al. 2012). The current 
data indicate that during a comparable time period used to test context-induced drug-seeking 
(14 days), chronic EtOH + NIC co-abuse results in a significant increase in basal GLU levels 
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in the mPFC. Therefore, it is plausible that increased basal GLU levels in the mPFC may 
contribute to the behavioral manifestation of heightened drug-seeking.
Chronic NIC consumption increased the recovery/clearance of GLU in the mPFC which was 
not observed following equivalent consumption of NIC in the EtOH + NIC co-abuse group 
(Fig. 6; bottom panel). The increase in recovery/clearance suggests that chronic NIC 
consumption resulted in an increase in GLU release in the mPFC which produced a 
compensatory reaction of an increased removal of the neurotransmitter in an effort to 
maintain the homeostatic level of GLU in the region. The divergence in the alteration of the 
GLU system produced by chronic NIC (consistent basal levels, increased clearance) and 
EtOH + NIC (increased basal levels, no alteration in clearance) consumption would suggest 
that the additional consumption of EtOH in the co-abuse group inhibited the 
neuroadaptations observed in the NIC alone group or that co-abuse of EtOH + NIC activated 
distinct pathways that do not parallel that observed following NIC consumption.
A possible factor in the alterations observed in GLU functioning within the mPFC could 
have been exposure to isoflurane anesthetic. Isoflurane interacts with GABA-A receptors 
and can produce memory deficits (Zurek et al., 2012, Saab et al., 2010). However, such 
memory deficits generally disappear within 72 hrs and it is likely that the effects of 
isoflurane would have dissipated during the 7-day interval between surgery and the 
microdialysis and ICSA experiments.
In general, the current data indicate that chronic EtOH and NIC self-administration results in 
unique neuroadaptations, that are not observed following equivalent EtOH or NIC self-
administration, which alter the rewarding properties of NIC within the AcbSh and GLU 
activity within the mPFC. However, it is not possible with the current experimental design to 
determine if the effects observed were due to the chronic co-abuse of EtOH and NIC or if 
the effects were a factor of the co-abuse of these drugs coupled with drug-free period of 
imposed abstinence. Since the majority of alcoholics and NIC-dependent individuals co-
abuse/use EtOH and NIC, the successful development of pharmacotherapeutics for the 
treatment of these disorders will be predicated upon a better understanding of the interaction 
between these two drugs within the brain.
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Fig. 1. 
Represents the mean (± SEMs) number of infusions into the AcbSh by P rats for all 
concentrations of NIC during the initial four ICSA sessions for the water (n = 36), EtOH (n 
= 36), NIC (n = 31), or EtOH + NIC (n = 32) groups. Rats in the EtOH + NIC group 
exhibited a significantly higher number of self-infusions for 1.0 and 3.0 μM NIC compared 
to all other groups (p < 0.0001). Similarly, EtOH + NIC exposed animals self-infused 
significantly more 0.3 μM NIC than their cohorts in the water, EtOH, or NIC groups. 
Animals that had previously self-administered water, EtOH, or NIC exhibited a significantly 
higher number of self-infusions for 3.0 μM NIC than their counterparts in all other groups (p 
< 0.001).
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Fig. 2. 
Displays the data for mean (± SEMs) number of lever responses on the active and inactive 
levers for the water (n = 6), EtOH (n = 7), NIC (n = 7), or EtOH + NIC (n = 6) groups 
during 7 sessions of ICSA testing with 0.3 μM NIC. Only animals that had previously 
consumed EtOH + NIC exhibited a significant active lever preference for 0.3 μM NIC 
(sessions 2–4; p< 0.001). Following aCSF substitution (sessions 5 and 6), reinstatement of 
0.3 μM NIC (session 7) produced a robust increase in active lever responding compared to 
both the inactive lever and pre-substitution level responding (p < 0.0001).
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Fig. 3. 
Shows the data for mean (± SEMs) number of lever responses on the active and inactive 
levers for the water (n = 8), EtOH (n = 7), NIC (n = 7), or EtOH + NIC (n = 6) groups across 
7 sessions of ICSA testing with 1.0 μM NIC. * Only animals in the EtOH + NIC group 
exhibited a significant active lever preference for 1.0 μM NIC (sessions 1–4 and 7; p< 
0.001).
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Fig. 4. 
Represents the data for mean (± SEMs) number of lever responses on the active and inactive 
levers for the water (n = 8), EtOH (n = 6), NIC (n = 6), or EtOH + NIC (n = 6) groups across 
7 sessions of ICSA testing with 3.0 μM NIC. * Rats in all four groups exhibited a significant 
active lever discrimination for 3.0 μM NIC (p < 0.001). + Animals that had previously self-
administered EtOH + NIC exhibited a significantly higher level of responding on the active 
lever compared to all other groups (sessions 2–4 and 7; p < 0.0001). Animals did not show 
lever discrimination during aCSF substitution (sessions 5 and 6).
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Fig. 5. 
Representative probe placements within the medial prefrontal cortex (mPFC). Animals with 
probe placements outside of this area were excluded from analyses.
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Fig. 6. 
Displays the mean (± SEMs) basal extracellular levels (top panel) and clearance (bottom 
panel) of GLU in the mPFC of naïve (n = 8), EtOH (n = 7), EtOH + NIC (n = 6), SAC + 
NIC (n = 6), and SAC alone (n = 7) groups. * Animals in the EtOH + NIC group exhibited 
significantly higher basal extracellular levels of GLU compared to all other groups (p < 
0.05). + Rats in the SAC + NIC group exhibited a significantly higher level of GLU 
clearance within the mPFC (p < 0.05).
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